BK
Basant Kumar Singh
About Basant Kumar Singh
Data last updated:
Basant Kumar Singh is a Managing Director at Basdils Pharmaceuticals Private Limited (since 2017). The companies operate in Trading and Pharma. Basdils Pharmaceuticals Private Limited reported revenue of ₹10 Lakh (FY 2024). Earlier, Basant Kumar Singh was a Director at Emedi Pharmaceuticals Private Limited (2015–2016).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 20 Jan 2017 | 2017 | ₹10 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 Jul 2015 | 2015 | ₹7.18 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Basant Kumar Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dilasa Kumari | 07210060 | Basdils Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Basant Kumar Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Basant Kumar Singh
Basant Kumar Singh currently holds 1 directorship: Basdils Pharmaceuticals Private Limited (Managing Director, since 20 Jan 2017, revenue βΉ10 Lakh (FY 2024)).
Basant Kumar Singh was first appointed on 03 Jul 2015 as Director at Emedi Pharmaceuticals Private Limited. The most recent appointment on record is 20 Jan 2017 at Basdils Pharmaceuticals Private Limited.
Basant Kumar Singh held 1 earlier board appointment: Emedi Pharmaceuticals Private Limited (Director, 03 Jul 2015 to 06 Aug 2016).
The current boards of Basant Kumar Singh's companies include Dilasa Kumari (Basdils Pharmaceuticals Private Limited).